Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Pharmaceutical Research|November 26, 2013
The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease?I IrwinLife Sciences|January 21, 1985
Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?I Irwin, J W LangstonLife Sciences|February 23, 1987
4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicityI Irwin, J W Langston, L E DeLanneyLife Sciences|February 23, 1987
The biotransformation of MPTP and disposition of MPP+: the effects of agingJ W Langston, I Irwin, L E DeLanneyNeurotoxicology|July 14, 2000
Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in miceD M McGrew, I Irwin, J W LangstonActa Neurologica Scandinavica. Supplementum|January 1, 1984
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspectsJ W Langston, E B Langston, I IrwinScience (New York, N.Y.)|February 25, 1983
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesisJ W Langston, P Ballard, J W Tetrud, et al.Neurology|June 1, 1994
Parkinsonism caused by petroleum waste ingestionJ W Tetrud, J W Langston, I Irwin, et al.Neuroscience Letters|June 5, 1989
The biodisposition of MPP+ in mouse brainI Irwin, L E DeLanney, D Di Monte, et al.Science (New York, N.Y.)|September 28, 1984
Pargyline prevents MPTP-induced parkinsonism in primatesJ W Langston, I Irwin, E B Langston, et al.Pageof 8